logo
Mark Cuban Says He's ‘All for DOGE' — but Has This Problem With How Musk Is Doing It

Mark Cuban Says He's ‘All for DOGE' — but Has This Problem With How Musk Is Doing It

Yahoo12-05-2025

Elon Musk's work as head of the Department of Government Efficiency (DOGE) has come under heavy criticism in certain quarters — partly because of anger that the world's richest person is cutting government programs designed to help lower- and middle-income Americans. One critic is billionaire entrepreneur Mark Cuban, though his problem isn't necessarily with DOGE's mission.
Trending Now:
Check Out:
In fact, Cuban said he's 'all for DOGE' during a recent appearance on Scott Galloway's podcast, 'The Prof G Pod.' The problem, according to Cuban, is the way DOGE has been implemented.
'I'm all for DOGE,' he said. 'I think it's a great idea to cut government. It's too big. It's too expensive. But you don't do it all at once. That is the definition of lack of strategic thinking.'
GOBankingRates breaks down Cuban's line of thinking when it comes to his criticism of the new federal agency and Musk.
DOGE is a non-official organization created by President Donald Trump to drastically downsize the federal government. Musk initially said he would slash $2 trillion from the federal budget, The Atlantic reported. But that target has since been revised downward to as low as $150 billion. Meanwhile, Musk recently announced plans to 'step back' from DOGE and focus on his job as Tesla CEO.
Even though the DOGE savings have been revised downward, the human impact is already substantial. Roughly 200,000 federal workers have been laid off since Trump took office, according to White House figures cited by Reuters. Whole agencies have been eliminated — and numerous U.S. communities are scrambling to deal with it.
Read Next:
'When you do it all at once, there's no chance for communities, cities, states to adapt at all, or participate, or put in processes or plans, or help people find other jobs, or replace lost revenue,' Cuban said. 'Small cities… [are] far more reliant on federal spending than bigger cities are.'
As an example, he pointed to a U.S. Treasury Department office in Parkersburg, West Virginia, that has faced DOGE cuts. The office employees about 2,000 people in a town of only 29,000 residents, according to Cuban.
'If those cuts continue, that's a disproportionate impact on Parkersburg and the area,' he said.
Cuban also cited cuts to coal mining safety programs and jobs throughout Appalachia.
'They've cut back on the monitors and the people who evaluate safety,' he said. 'That has a significant impact on those communities. Not only did they lose the jobs, but there's nobody dealing with mining safety.'
Cuban's recommendation would have been to stagger the cuts over 12 to 18 months so communities would have more time to prepare for job losses.
'If they had done it that way, Elon might have been a hero for doing it the right way,' he said.
Cuban isn't the only billionaire to push back against Musk and DOGE. Philanthropist and Microsoft co-founder Bill Gates blasted Musk for cutting funding to the U.S. Agency for International Development (USAID), an agency set up to provide food and care for impoverished communities worldwide.
'The world's richest man has been involved in the deaths of the world's poorest children,' Gates said in a recent interview with The New York Times Magazine.
Editor's note on political coverage: GOBankingRates is nonpartisan and strives to cover all aspects of the economy objectively and present balanced reports on politically focused finance stories. You can find more coverage of this topic on GOBankingRates.com.
More From GOBankingRates
5 Types of Vehicles Retirees Should Stay Away From Buying
How Far $750K Plus Social Security Goes in Retirement in Every US Region
4 Things You Should Do if You Want To Retire Early
12 SUVs With the Most Reliable Engines
Sources
The Prof G Pod – Scott Galloway (YouTube), 'Mark Cuban – Do We Need an Elon of the Left? | Raging Moderates.'
The Atlantic, 'The Actual Math Behind DOGE's Cuts.'
Reuters, 'US federal employment drops again as DOGE cuts stack up.'
The New York Times Magazine, 'The $200 Billion Gamble: Bill Gates's Plan to Wind Down His Foundation.'
This article originally appeared on GOBankingRates.com: Mark Cuban Says He's 'All for DOGE' — but Has This Problem With How Musk Is Doing It

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump Ready to Ditch His Tesla Car amid Musk Fallout: 'I Might Just Get Rid of It'
Trump Ready to Ditch His Tesla Car amid Musk Fallout: 'I Might Just Get Rid of It'

Business Insider

time13 minutes ago

  • Business Insider

Trump Ready to Ditch His Tesla Car amid Musk Fallout: 'I Might Just Get Rid of It'

WASHINGTON — June 7, 2025 President Donald Trump is distancing himself from Elon Musk—publicly and materially. According to The Washington Post, Trump has told aides in recent days that he is considering selling or giving away the red Tesla (TSLA) Model S he purchased in March, a gesture that once symbolized his support for Musk. Confident Investing Starts Here: 'I might just get rid of it,' Trump told aides, according to a senior White House official who spoke on the condition of anonymity. The car, still parked near the White House as of this week, has become a visible casualty of the rapidly souring relationship between Trump and Musk. The split followed Musk's harsh criticism of the administration's latest domestic policy bill, which he publicly called a 'disgusting abomination.' That comment triggered a sharp response from the president, both publicly and privately. On Air Force One, when asked by a reporter about Musk's alleged drug use, Trump replied: 'I don't want to comment on his drug use. I don't know what his status is.' 'I read an article in The New York Times. I thought it was, frankly, it sounded very unfair to me.' But privately, Trump has reportedly told associates that Musk is 'crazy' and blamed his behavior on drug use, according to The New York Times. Musk Gave No Public Comment on the Car—But a Hint at Peace? As of Saturday afternoon, Elon Musk has not issued any public statement specifically addressing Trump's decision to unload the Tesla. However, he did respond to a suggestion from investor Bill Ackman on X that the two men should reconcile for the good of the country. 'You're not wrong,' Musk replied—his only recent public comment that could be interpreted as a gesture toward de-escalation. Beyond that, Musk has been active on X in recent days, directing criticisms at others, including Steve Bannon and critics of Tesla, but has avoided commenting directly on Trump's actions regarding the car or federal contracts. Trump Weighs Tesla Breakup The sale—or symbolic disposal—of the Tesla would mark a final, visual severing of a political and personal alliance that once had significant policy weight. Musk had been one of Trump's most prominent business backers, and the March purchase of the Model S was, at the time, framed by aides as a nod of approval to the entrepreneur's role in the administration. Now, according to officials, the car is being referred to inside the West Wing as a political relic. And while no final decision has been made, staff say it's become a quiet but pointed symbol of Trump's intent to distance himself from Musk for good. Trump himself, speaking about Musk during a press gaggle on June 6, said: 'I'm very disappointed in Elon. I've helped Elon a lot.' Whether the car is sold, donated, or simply removed from view, it now stands as a monument to one of the most dramatic falling-outs in recent political history. Is Tesla Stock Still a Buy? Meanwhile, Wall Street isn't exactly bullish on Musk's flagship automaker. According to TipRanks, Tesla currently holds a 'Hold' rating based on 37 analyst reviews over the past three months. It's a split camp: 16 analysts rate it a Buy, 10 say Hold, and 11 recommend Sell — a clear reflection of the uncertainty swirling around the company. The market seems just as cautious. The average 12-month price target for TSLA is $284.37, suggesting a 3.7% downside from its current level.

Bitcoin rebounds above $104,700 after initial dip on Trump-Musk fallout
Bitcoin rebounds above $104,700 after initial dip on Trump-Musk fallout

Business Upturn

time34 minutes ago

  • Business Upturn

Bitcoin rebounds above $104,700 after initial dip on Trump-Musk fallout

Bitcoin (BTC) staged a smart recovery on Friday, climbing back above the $104,700 mark after an early dip sparked by jitters in the market following the reported fallout between former US President Donald Trump and tech billionaire Elon Musk. As per latest data, Bitcoin was trading at $104,731.41, up 2.18% over the past 24 hours. The cryptocurrency saw a volatile session, hitting an intraday low of $102,405.29 before bouncing back sharply to test a high of $105,333.00. The market had initially reacted negatively to reports of strained relations between Trump and Musk, which had raised concerns about potential policy shifts or regulatory overhang on digital assets in the US. The development triggered a broad risk-off sentiment across major cryptocurrencies during early trade. However, BTC's resilience was on display as buyers stepped in at lower levels, fueling a strong rebound. The 24-hour trading volume stood robust at 14,435.76 BTC, with $1.5 billion USDT turnover, indicating healthy participation on the bounce. Crypto market analysts noted that despite short-term headlines, underlying bullish momentum in BTC remains intact amid improving institutional interest and optimism around the next leg of mainstream adoption. Traders will be watching closely for further developments on the Trump-Musk front, along with upcoming macroeconomic cues, which could influence BTC's near-term trajectory. Note: $BTC price at the time of writing this article. News desk at

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Yahoo

time2 hours ago

  • Yahoo

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store